
Icn Pharmaceuticals, Inc.
Free shipping on orders over $99 · 30-day returns
URIC ACID PROCEDURE, TEKPOINT DIRECT is an FDA 510(k)-cleared medical device (K770459) manufactured by Icn Pharmaceuticals, Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on April 28, 1977. Regulation: 8.